Atlas Trials

Maintenance of Tarceva (Erlotinib) in Patients With Locally Advanced Head and Neck Cancer

Clinical trial NCT00750555 · TERMINATED

Trial details

NCT number
NCT00750555
Sponsor
Geisinger Clinic
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2008-09-01
Primary completion
2009-12-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.